A study evaluating benralizumab treatment in patients with eosinophilic granulomatosis with polyangiitis and severe asthma
Latest Information Update: 03 Feb 2023
At a glance
- Drugs Benralizumab (Primary)
- Indications Asthma; Granulomatosis with polyangiitis
- Focus Pharmacodynamics; Therapeutic Use
Most Recent Events
- 03 Feb 2023 New trial record